Introduction: The extraocular muscles (EOMs) are considered a separate class of skeletal muscle, allotype. Myosin is the major contractile protein in muscle. The myosin heavy chain (MyHC) isoforms are the best molecular markers of functional heterogeneity of muscle fibers. The relaxation rate, reflects the rate at which Ca2+ is transported back into the sarcoplasmic reticulum (SR) mostly by SR Ca2+ATPase (SERCA). Myosin binding protein C (MyBP-C), plays a physiological role in regulating contraction. The laminins (Ln) are the major non-collagenous components of the basement membrane (BM) surrounding muscle fibers and are important for muscle fiber integrity. Methods: Adult human EOMs were studied with SDS-PAGE, immunoblots and immunocytochemistry, the latter with antibodies against six MyHC, 2 SERCA, 2 MyBP-C and 8 laminin chain isoforms. The capillary density was also determined. Results: Most fibers contained a mixture of MyHC isoforms. Three major groups of fibers could be distinguished. Fast fibers that stained with anti-MyHCIIa, slow fibers that stained with anti-MyHCI and MyHCeompos/MyHCIIaneg-fibers that stained with neither of these antibodies but with anti-MyHCI+IIa+eom and anti-MyHCeom. A majority of the fibers contained both SERCA1 and 2 whereas 1% were unstained with both antibodies. Biochemically SERCA2 was more abundant than SERCA1. MyBP-Cfast was not present in the EOMs and MyBP-Cslow was only detected immunocytochemically. The extrasynaptical BM of the EOM muscle fibers contained Lna2, b1, b2, g1, a4 and a5 chains. The capillary density in the EOMs was very high (1050 +/-190 capillaries/mm2) and significantly (p<0.05) higher in the orbital than in the global layer. Conclusions: The co-existence of complex mixtures of several crucial protein isoforms provide the human EOMs with a unique molecular portfolio that a) allows a highly specific fine-tuning regime of contraction and relaxation, and b) imparts structural properties that are likely to contribute to protection against certain neuromuscular diseases.

Terrestrial salamanders of the genus Plethodon are among many vertebrates possessing both main olfactory and vomeronasal systems, which the Volatility Theory posits are for detection of volatile and soluble olfactory cues, respectively. Further recent work showing a high amount of convergence between the two olfactory subsystems at the level of the central nervous system suggests complementary or overlapping roles for them. This study examined the use of the olfactory subsystems in prey detection from the perspectives of behaviour and neurobiology. Red-backed salamanders, Plethodon cinereus, were observed in standardized behavioural assays with both volatile and soluble prey olfactory cues. Naïve salamanders showed an increase in nosetapping as well as a side preference in the presence of soluble and volatile prey cues when tested in a 22°C day/20°C night room. In a 15°C day /12°C night room, salamanders increased nosetapping in the presence of soluble prey cues. Salamanders showed a pattern of responses that differed based on their previous experience with the assay, as well as the temperature of the testing room. Attempts to study the neurobiology of olfactory function in Plethodon shermani were inconclusive up to this point, but future directions are discussed. This study shows the importance of olfaction in prey detection by salamanders and that prey searching behaviour is exhibited in the exclusive presence of olfactory cues.

Gefährdete Spezies in Menschenobhut zu reproduzieren und zu erhalten soll dem weltweiten Rückgang zahlreicher Papageienarten entgegenwirken. Der Erfolg solcher Zuchtprogramme wird unter anderem durch begrenzte Kenntnisse über physiologische und pathologische Vorgänge im Fortpflanzungssystem dieser Vogelordnung erschwert. Ziel der vorliegenden Arbeit war die Etablierung aussagekräftiger Parameter zur Einordnung des Reproduktionsstatus von männlichen Papageienvögeln. Dabei wurde ein Probenumfang fixierter, männlicher Reproduktionsorgane acht verschiedener Gattungen mit standardisierten histologischen und immunzytochemischen Methoden untersucht. Im Vordergrund stand die morphologische Beurteilung der untersuchten Gonaden im Bezug auf Fortpflanzungsaktivität und -status. Gleichzeitig sollten die immunzytochemischen Analysen Aufschluss über die beteiligten Hormone und Enzyme geben. Für die Etablierung vogel-spezifischer Marker wurde als Vertreter der Psittaciformes der Wellensittich (Melopsittacus undulatus, n=45) als Modellspezies ausgewählt. 15 verschiedene Antikörper aus der Gruppe der Steroidrezeptoren, steroidogenen Enzyme, Relaxinpeptide und Proliferationsmarker wurden an dieser Art getestet. Anschließend erfolgte der Transfer der erarbeiteten Methodik auf sieben weitere Papageiengattungen (Nymphicus, Eolophus, Cacatua, Psittacus, Amazona, Ara, Cyanopsitta). Anhand der Histologie konnten alle untersuchten Gonaden den drei verschiedenen Reproduktionsstadien aktiv, intermediär und inaktiv zugeordnet werden. Hierbei wurden Kriterien wie die Ausdehnung von Samenkanälchen und Interstitium, Morphologie des Keimepithels, Vorhandensein von Lipofuszin in den Samenkanälchen sowie die Teilungsaktivität von Keimzellen herangezogen. Aktive Hoden zeigen ausgedehnte Tubuli und ein schmales Interstitium, ein Keimepithel mit allen Keimzellstadien, wenig Lipofuszin und eine hohe Teilungsaktivität bei den Keimzellen. Inaktive Hoden hingegen besitzen schmale Tubuli und ein breites Interstitium, ein Keimepithel bestehend aus Sertoli-Zellen und Spermatogonien, Massen an Lipofuszin im Lumen der Samenkanälchen und eine geringe Proliferationsrate der Keimzellen. 14 der 15 getesteten Marker konnten mittels Immunzytochemie erfolgreich am Wellensittich etabliert werden. Hinsichtlich der Einordnung des Reproduktionsstatus war in erster Linie ein Absinken der steroidogenen Enzymaktivität von 3β-Hydroxysteroid-Dehydrogenase (HSD) und 17β-HSD-2 bei sexuell inaktiven gegenüber aktiven und intermediären Tieren zu verzeichnen. Auch der Androgenrezeptor (AR) wurde im Ruhestadium nicht mehr exprimiert. Die übrigen Steroidrezeptoren, steroidogenen Enzyme und Relaxinpeptide zeigten variable zelluläre Verteilungsmuster, die keine klare Aussage zum Fortpflanzungsstatus zuließen. Dennoch konnten anhand der Lokalisation dieser Faktoren in Keimzellen, somatischen Zellen des Hodens und Zellen des Nebenhodenepithels funktionelle Gesichtspunkte geklärt werden. Beispielsweise zeigte die Koexistenz des Östrogenrezeptors ERα und des steroidogenen Enzyms Aromatase in Hoden und Nebenhoden, dass nicht nur androgene Einflüsse in die Steuerung der Gonaden involviert sind. Auch der erstmalige Nachweis von Relaxin, Relaxin-like factor und ihren Rezeptoren in testikulären und epididymalen Zellen deutet darauf hin, dass diese die Funktion der beim Vogel nicht vorhandenen Prostata übernehmen. Zudem ist der Transfer der etablierten immunzytochemischen Methoden auf sieben weitere Papageiengattungen (Nymphicus, Eolophus, Cacatua, Psittacus, Amazona, Ara, Cyanopsitta) gelungen. Auch hier konnten 14 Marker in verschiedenen Zellen von Hoden und Nebenhoden sichtbar gemacht werden. Die teilweise heterogene Verteilung der Marker in verschiedenen Zelltypen war eindeutig spezies-abhängig. Dies hat gezeigt, dass die beim Wellensittich mittels Immunzytochemie erzielten Resultate nur eingeschränkt auf andere Papageienspezies übertragbar sind. Entscheidend für die Beurteilung des Reproduktionsstatus ist daher die individuelle Auswahl der Marker in Abhängigkeit von der untersuchten Spezies. Die Resultate dieser Studie liefern die Grundlage für weitere Forschungsansätze in der Reproduktionsdiagnostik von Papageienvögeln. Zum einen können die etablierten Marker in Analyse-Systemen zum Einsatz kommen, die nicht-invasiv gewonnene Medien (z. B. Faezes) untersuchen und vor allem in Zuchterhaltungsprogrammen bedrohter Arten hilfreich sind. Zum anderen ist die immunzytochemische Untersuchung von Hodenbioptaten pathologisch veränderter Hoden (z. B. Tumoren oder Entzündungen) als eine sinnvolle Ergänzung der Diagnostik von Infertilität bei männlichen Psittaziden anzusehen.

At the beginning of this study, the granule localisation and regulation of release of human neutrophil (PMNL) precursor collagenases, proMMP-8 and -9 (type I and type TV/V collagenases, respectively), enzymes highly active against the extracellular matrix (ECM) and thought to be relevant in invasion and inflammation, had been established while that of their inhibitor, tissue inhibitor of matrix metalloproteinases-I (TIMP-1), had not. Electron microscopy immunogold labelling of cryoultramicrotomy sections for granule marker proteins, lysosome-associated membrane proteins (LAMPs) and endocytosed bovine serum albumin-coated gold probes, followed by stereology, established that TIMP-1 was mainly located in a distinct oval, electron translucent organelle, a little larger than azurophil granules. A lack of labelling for endocytic markers and for glycosylphosphatidylinositol-anchored proteins, established using granule fractionation and immunolabelling to be markers for the secretory vesicles, and LAMPs-1 and -2, indicated the non-endosomal, non-secretory and nonlysosomal nature of this organelle. Density gradient cofractionation with the least dense secretory vesicle population and some pleiomorphism of the organelle suggested that it is a "vesicle" rather than a "granule" population. Colocalisation with proMMP-9 in minor subpopulations suggests that TIMP-1 vesicle biogenesis occurs between metamyelocytic and termination differentiation, but before secretory vesicle synthesis. Immunolabelling of phagocytosed and pulse-chased IgG-opsonised latex beads showed that specific and azurophil granules and a small number of proMMP-8-containing granules (a specific granule subpopulation) fuse with the phagosome whereas the TIMP-1 vesicle and proMMP-9-containing granules do not, suggesting that the latter play no role in phagosomal destruction of IgG-opsonised bacteria and that their phagosomal release is not calcium regulated. However, studies using the calcium ionophore, ionomycin, and monitoring extracellular granule marker protein release upon addition of increasing levels of extracellular calcium, showed that all granules, except the TIMP-1 vesicle, appeared to be calcium regulated. This suggests that the regulation of proMMP-9 release is not exclusively via calcium and that TIMP-1 vesicle release is not calcium regulated. Whereas most granules were shown to be associated with microtubule-like structures, the TIMP-1 vesicle and proMMP-9-containing granules were shown to associate with two morphologically different cytoskeletal elements, neither resembling actin nor tubulin. These elements, and the release of the TIMP-1 vesicle and proMMP-9-containing granules, need to be studied further, but results achieved to date may explain the observed differential mode of release of TIMP-1 relative to proMMP-9. The proMMP-9-binding and inhibitory capacity of a 66 kDa high molecular mass form of TIMP-1 was demonstrated in PMNL homogenates and plasma using western ligand blots and a novel reverse zymography method. The role and relevance of this form remains unknown as does the relevance and potential role of proMMP-9ffIMP-1 complexes seen during isolation procedures. The proMMP-9ffIMP-1 complex may occur in vivo, as evidenced by immunolocalisation studies, and, together with TIMP-1 released from its own discrete vesicle population, may be responsible for the fine regulation of extracellular proteolysis. / Thesis (Ph.D.)-University of Natal, Pietermaritzburg, 2002.

Inflammation is the normal biological response to tissue injury, and is characterised by the interactive activation of multiple mediators and cell types. One response to tissue injury is the production of pain, not only by direct trauma to sensory fibres, but also through the release of mediators from sensory nerve terminals. One such mediator is kinin which is a vasoactive peptide considered to play a primary role in inflammation by causing constriction of venules, dilation of arterioles, increasing permeability of the capillary membrane, and interacting with sensory nerve terminal transmitters to evoke pain. The kinin forming enzymes (kallikreins) reach inflammation sites either on the surface of migrating neutrophils or by transudation from plasma. The kininogen molecule which contains the kinin moiety, has been localised on the external surface of the neutrophil, and provides the substrate from which kinins can be cleaved through enzymatic action. The cellular actions of kinins are mediated through B2 receptors, which are also located on the external surface of the neutrophils. In addition, the induced effects of kinins are regulated by B1 receptors. The formation of nitric oxide (NO) from arginine released from the kinin C terminus, and receptor membrane signal transduction by nitric oxide following kinin receptor activation is discussed. A molecular response to cell injury is the formation of chemotactic mediators that attract neutrophils to sites of inflammation. The question whether neutrophils contribute to circulating levels of kinins was examined in infections and inflammatory disorders. This novel hypothesis was tested using circulating neutrophils harvested from patients with tuberculosis meningitis and pneumonia. These neutrophils showed a distinct loss of only the kinin moiety from the kininogen molecule located on the external surface. The confocal images of fixed, permeabilised neutrophils provided multi-dimensional constructs, and the intensity of fluorescence reflected the relative amounts of the molecule present in both neutrophils harvested from healthy volunteers as well as patient blood. The immunocytochemical labelling experiments using colloidal gold as markers, confirmed, at the ultrastructural level, the presence or disappearance of the kinin moiety from the kininogen molecule on the neutrophil surface. The cell component of synovial fluid in rheumatoid athritis (RA) consists mainly of neutrophils. This study demonstrates the absence of the kinin moiety from circulating and synovial fluid neutrophils from patients with RA, as well as an increased signal from immunolabelled B2 receptors in synovial fluid neutrophils. These findings support the hypothesis that in RA, kinins are released during the inflammatory response in the joints, and suggests that there is an upregulation of the B2 receptor at the site of inflammation. Neutrophils chemotactically drawn to the site of inflammation become activated to release kinin from the kininogen molecule, and thereafter re-enter the circulation where they were harvested systemically. B2 receptors may be upregulated following activation by kinins or by other mediators present in the inflammatory milieu. Interleukin-1 has been shown to upregulate kinin receptors on human synovial cells. Anti-peptide antibodies to the loops of cloned B1 and B2 receptors have provided powerful probes for the cellular identification of the two kinin receptor families. Mapping of the B2 receptors showed upregulation on the neutrophils gathered from inflamed joints. However, no activation of the Br receptors was observed in normal blood neutrophils as well as those obtained from the different disease states. / Thesis (M.Med.)-University of Natal, 1996.

Das corneale Endothel bildet die innere, einschichtige Zelllage der Cornea und ist für die Aufrechterhaltung der cornealen Transparenz zuständig. Krankheiten oder Verletzungen des cornealen Endothels können zu schweren Beeinträchtigungen des Sehvermögens führen und eine corneale Transplantation erforderlich machen. Der während und nach der Operation auftretende endotheliale Zellverlust erschwert das Überleben des Transplantates. Darum besteht ein Hauptziel des cornealen Tissue Engineerings in der Bereitstellung von transplantierbaren humanen cornealen Endothelzellsheets (HCEC-Sheets) mit einer adäquaten Zelldichte. Thermo-responsive Zellkulturträger fanden für die schonende, enzymfreie Gewinnung von Zellsheets für verschiedene Gewebetypen bereits Verwendung. HCEC stellen in diesem Kontext einen besonderen Fall dar, da sie eine starke Adhäsion zu ihrem Kultursubstrat ausbilden, was deren schonende, thermisch induzierte Ablösung als funktionelles Zellsheet erschwert. Im Rahmen dieser Arbeit wurde ein neuartiger thermo-responsiver Zellkulturträger entwickelt. Dieser basiert auf dem durch Elektronenbestrahlung immobilisierten und vernetzten thermo-responsiven Polymer Poly(vinylmethylether) (PVME) sowie dem alternierenden Co-Polymer Poly(vinylmethylehter-alt-maleinsäureanhydrid) (PVMEMA) als biofunktionalisierbare Komponente. Die Kombination dieser Polymere führte zur Etablierung eines thermo-responsiven Zellkulturträgers, dessen physikochemische und biomolekulare Eigenschaften in weiten Grenzen einstellbar und dadurch an die spezifischen Anforderungen von HCEC anpassbar waren. Das PVME-PVMEMA-Blend ermöglichte die Bildung konfluenter HCEC-Monolayer mit den morphologischen Grundlagen für ein funktionelles corneales Endothelgewebe. Durch Inkorporation von Poly(N-isopropylacrylamid) (PNiPAAm) als weitere thermo-responsive Polymerkomponente konnte das Ablösungsverhalten funktioneller HCEC-Sheets weiter verbessert werden. In einem weiteren Schritt erfolgte der Transfer abgelöster HCEC-Sheets auf ein planares, biofunktionalisiertes Kultursubstrat sowie auf endothelfreie porcine Corneae. Die HCEC-Sheets wurden auch nach dem Transfer umfassend biologisch analysiert. Diese Arbeit legt einen Grundstein für die Bereitstellung klinisch anwendbarer Alternativen für das Tissue Engineering von cornealem Gewebe.

As efusões cavitárias são de ocorrência frequente na rotina clínica de cães. Na maior parte dos casos são efusões benignas, causadas por distúrbios hidrostáticos do sistema circulatório. As neoplasias são causas comuns de efusões em cães, contudo, nem sempre as células tumorais são encontradas no exame citopatológico. A dosagem de marcadores tumorais e o exame imunocitoquímico são alternativas para tornar o diagnóstico de neoplasia em efusões mais preciso. Os objetivos deste trabalho foram dosar os seguintes marcadores tumorais bioquímicos: antígeno carcinoembrionário (CEA), antígeno associado a câncer 72-4 (CA 72-4) e fragmento de citoqueratina 21-1 (CYFRA 21-1), que ainda não tiveram seu desempenho avaliado em efusões neoplásicas e não neoplásicas caninas, bem como marcadores imunocitoquímicos que incluem dois novos anticorpos primários (MOC-31 e D2-40) para a diferenciação entre carcinoma e mesotelioma. Trinta e duas amostras de líquidos cavitários abdominais e torácicos, provenientes do atendimento clínico do Hospital de Clínicas Veterinárias da Universidade Federal do Rio Grande do Sul foram analisadas. De acordo com o exame citopatológico e ficha clínica do animal essas efusões foram classificadas em dois grupos: neoplásico e não neoplásico. A dosagem dos marcadores tumorais foi realizada pelo método imunoenzimático sanduíche (ELISA), conforme as instruções dos fabricantes. Para a avaliação imunocitoquímica foram utilizadas 14 amostras de efusões neoplásicas. A técnica foi realizada pelo método estreptavidina-biotina ligada a peroxidase ou a fosfatase alcalina, utilizando-se como cromógeno o DAB. Os marcadores tumorais CEA e CA 72-4 não tiveram resultados significativos na diferenciação entre efusões neoplásicas e não neoplásicas, enquanto que o CYFRA 21-1 obteve sensibilidade de 70%, especificidade de 94% e acurácia de 81% para o diagnóstico neoplásico. Em todas as amostras neoplásicas, imunocitoquímica e citopatologia foram compatíveis, verificando-se como válida a padronização dos novos anticorpos para a espécie canina. Este estudo demonstrou que novos marcadores tumorais, tanto bioquímicos como imunocitoquímicos, podem ser empregados no diagnóstico de neoplasias caninas. O marcador tumoral CYFRA 21-1 deve ser utilizado como auxílio diagnóstico para a espécie canina e os anticorpos MOC-31 e D2-40 devem ser incluídos em painéis imunocitoquímicos de rotina para a diferenciação entre carcinomas e mesoteliomas em efusões neoplásicas. / The cavity effusions frequently occur in the clinical routine of dogs. In most cases the effusions are benign caused by circulatory system disorders. Neoplasms are common causes of effusions in dogs, however not always the tumor cells are found in cytopathologycal analysis. The dosage of tumor markers is an alternative to make the neoplastic effusion diagnosis more accurate. The aims of this work were to determine the following biochemical tumor markers: carcinoembryonic antigen (CEA), cancer antigen 72-4 (CA 72-4) and cytokeratin fragment 21-1 (CYFRA 21-1), which have not had their performance evaluated in canine neoplastic and non-neoplastic effusions, as well as immunocytochemical markers including two new primary antibodies (MOC-31 and D2-40) for differentiation between carcinoma and mesothelioma tumors. Thrirtytwo samples of abdominal and thoracic cavity fluids, from the clinical care of the Veterinary Hospital of the Federal University of Rio Grande do Sul were analyzed. According to the cytopathology test and patient’s clinical record the effusions were classified in two groups: neoplastic or non-neoplastic. The tumor markers measurement was performed by sandwich enzyme immunoassay (ELISA) according to the manufacturer instructions. Fourteen neoplastic samples were used for the immunocytochemical tests. The tests were performed by streptavidin-biotin method linked to peroxidase or to alkaline phosphatase using the DAB chromogen. The tumor markers CEA and CA 72-4 had no significant results for differentiating between neoplastic and non neoplastic effusions, whereas the tumor marker CYFRA 21-1 obtained 70% of sensibility, 94% of specificity and 81% of accuracy for the neoplastic diagnosis. In all neoplastic samples the immunocytochemical and cytological tests were compatible, which make valid their use for standardization of those new antibodies for the canine species. This study demonstrated that new tumor markers both biochemical and immunocytochemical could be used in the canine neoplastic diagnosis. The tumor marker CYFRA 21-1 must be used for the canine species, and the antibodies MOC-31 and D2-40 must be included in routine immunocytochemistry panel for the differenciation between carcinoma and mesothelioma in neoplastic effusions.

Made available in DSpace on 2016-12-08T16:24:17Z (GMT). No. of bitstreams: 1 PGCA14MA131.pdf: 1544474 bytes, checksum: 4f496b43924d95177e7139e1fc3bca48 (MD5) Previous issue date: 2014-02-25 / This study aimed to investigate the use of immunocytochemistry (ICC) as a quick diagnostic method of rabies, and to perform a retrospective study of positive rabies cases of the Animal Pathology Laboratory (LAPA/CAV) archives, by using immunohistochemistry (IHC). The study was divided into two stages: data collection from the LAPA/CAV archives between 1987 and 2011, through the processing of paraffin embedded samples for histopathology and IHC; and clinical follow-up of susceptible animals between the years of 2012 and 2013, in which naturally dead or euthanized animals were necropsied. Central nervous system samples were collected for immunocytochemistry assessment, in addition to direct immunofluorescence (DIF) and histopathology with hematoxylin and eosin staining. The retrospective study showed that the affected animals ages ranged from 4 months to 10 years. Most frequently reported clinical signs were incoordination of the hind limbs, progressing to decumbency and death in 2-7 days. Northeastern (Vale do Itajaí) and eastern Santa Catarina were the regions with most of the cases submitted to the laboratory. During the clinical follow-up stage 13 animals presented the paralytic form of the disease, and one showed the furious form. The histological alterations observed in both stages of the study consisted of mild to severe perivascular lymphocytic and macrophagic meningoencephalitis, sometimes with foci of gliosis and neuronal necrosis; Negri inclusion bodies were observed in 85% of the retrospective study cases and 88% of the clinically assessed animals. IHC was essential to the diagnosis conclusion in the retrospective study, especially those in which no Negri bodies were found. The ICC was positive in 85,7% (12/14) of the cases, including one animal whose direct immunofluorescence was negative, and also proved to be a fast and easy-to-perform test. Rapid diagnostic techniques are extremely important as they allow for prevention and control measures to be taken quickly / Este trabalho teve como objetivos utilizar a imunocitoquímica (ICQ) como método rápido de diagnóstico para raiva, e realizar estudo retrospectivo de casos positivos de raiva nos arquivos do Laboratório de Patologia Animal (LAPA/CAV), através da imunohistoquímica (IHQ). O estudo foi dividido em duas etapas, levantamento de dados entre os anos de 1987 e 2011 no LAPA/CAV, através de processamento das amostras mantidas em parafina, para histopatologia e imunohistoquímica (IHQ), e acompanhamento clínico de animais suspeitos entre os anos de 2012 e 2013, no qual bovinos mortos naturalmente ou eutanasiados foram necropsiados. Amostras de sistema nervoso central foram coletadas para aplicação de ICQ, além de imunofluorecência direta e histopatologia com coloração de Hematoxilina e Eosina. No estudo retrospectivo observou-se que a idade dos animais afetados variou de quatro meses a 10 anos. Os principais sinais clínicos relatados foram incoordenação dos membros posteriores, evoluindo para decúbito e morte em 2 a 7 dias. As regiões do vale e leste de Santa Catarina foram às com maior numero de casos remetidos ao laboratório. Durante o acompanhamento clínico 13 animais apresentaram a forma paralítica da doença e um bovino apresentou forma furiosa. As alterações histológicas observadas, nas duas etapas do trabalho consistiram em meningonecefalite linfocítica e macrofágica perivascular, variando de leve a acentuada, por vezes com focos de gliose e necrose neuronal; Corpúsculos de inclusão de Negri foram observados em 85% dos casos do levantamento e 88% dos animais acompanhados clinicamente. A IHQ foi essencial para a conclusão do diagnóstico nos casos do estudo retrospectivo, especialmente aqueles em que não foram observadas inclusões de Negri. A ICQ foi positiva em 85,7% (12/14) dos bovinos com raiva, inclusive em um animal cuja IFD foi negativa, além de se mostrar um teste rápido e de fácil execução. Técnicas que buscam o diagnóstico rápido são extremamente importantes, pois permitem que medidas de prevenção e controle possam ser tomadas mais rapidamente

As efusões cavitárias são de ocorrência frequente na rotina clínica de cães. Na maior parte dos casos são efusões benignas, causadas por distúrbios hidrostáticos do sistema circulatório. As neoplasias são causas comuns de efusões em cães, contudo, nem sempre as células tumorais são encontradas no exame citopatológico. A dosagem de marcadores tumorais e o exame imunocitoquímico são alternativas para tornar o diagnóstico de neoplasia em efusões mais preciso. Os objetivos deste trabalho foram dosar os seguintes marcadores tumorais bioquímicos: antígeno carcinoembrionário (CEA), antígeno associado a câncer 72-4 (CA 72-4) e fragmento de citoqueratina 21-1 (CYFRA 21-1), que ainda não tiveram seu desempenho avaliado em efusões neoplásicas e não neoplásicas caninas, bem como marcadores imunocitoquímicos que incluem dois novos anticorpos primários (MOC-31 e D2-40) para a diferenciação entre carcinoma e mesotelioma. Trinta e duas amostras de líquidos cavitários abdominais e torácicos, provenientes do atendimento clínico do Hospital de Clínicas Veterinárias da Universidade Federal do Rio Grande do Sul foram analisadas. De acordo com o exame citopatológico e ficha clínica do animal essas efusões foram classificadas em dois grupos: neoplásico e não neoplásico. A dosagem dos marcadores tumorais foi realizada pelo método imunoenzimático sanduíche (ELISA), conforme as instruções dos fabricantes. Para a avaliação imunocitoquímica foram utilizadas 14 amostras de efusões neoplásicas. A técnica foi realizada pelo método estreptavidina-biotina ligada a peroxidase ou a fosfatase alcalina, utilizando-se como cromógeno o DAB. Os marcadores tumorais CEA e CA 72-4 não tiveram resultados significativos na diferenciação entre efusões neoplásicas e não neoplásicas, enquanto que o CYFRA 21-1 obteve sensibilidade de 70%, especificidade de 94% e acurácia de 81% para o diagnóstico neoplásico. Em todas as amostras neoplásicas, imunocitoquímica e citopatologia foram compatíveis, verificando-se como válida a padronização dos novos anticorpos para a espécie canina. Este estudo demonstrou que novos marcadores tumorais, tanto bioquímicos como imunocitoquímicos, podem ser empregados no diagnóstico de neoplasias caninas. O marcador tumoral CYFRA 21-1 deve ser utilizado como auxílio diagnóstico para a espécie canina e os anticorpos MOC-31 e D2-40 devem ser incluídos em painéis imunocitoquímicos de rotina para a diferenciação entre carcinomas e mesoteliomas em efusões neoplásicas. / The cavity effusions frequently occur in the clinical routine of dogs. In most cases the effusions are benign caused by circulatory system disorders. Neoplasms are common causes of effusions in dogs, however not always the tumor cells are found in cytopathologycal analysis. The dosage of tumor markers is an alternative to make the neoplastic effusion diagnosis more accurate. The aims of this work were to determine the following biochemical tumor markers: carcinoembryonic antigen (CEA), cancer antigen 72-4 (CA 72-4) and cytokeratin fragment 21-1 (CYFRA 21-1), which have not had their performance evaluated in canine neoplastic and non-neoplastic effusions, as well as immunocytochemical markers including two new primary antibodies (MOC-31 and D2-40) for differentiation between carcinoma and mesothelioma tumors. Thrirtytwo samples of abdominal and thoracic cavity fluids, from the clinical care of the Veterinary Hospital of the Federal University of Rio Grande do Sul were analyzed. According to the cytopathology test and patient’s clinical record the effusions were classified in two groups: neoplastic or non-neoplastic. The tumor markers measurement was performed by sandwich enzyme immunoassay (ELISA) according to the manufacturer instructions. Fourteen neoplastic samples were used for the immunocytochemical tests. The tests were performed by streptavidin-biotin method linked to peroxidase or to alkaline phosphatase using the DAB chromogen. The tumor markers CEA and CA 72-4 had no significant results for differentiating between neoplastic and non neoplastic effusions, whereas the tumor marker CYFRA 21-1 obtained 70% of sensibility, 94% of specificity and 81% of accuracy for the neoplastic diagnosis. In all neoplastic samples the immunocytochemical and cytological tests were compatible, which make valid their use for standardization of those new antibodies for the canine species. This study demonstrated that new tumor markers both biochemical and immunocytochemical could be used in the canine neoplastic diagnosis. The tumor marker CYFRA 21-1 must be used for the canine species, and the antibodies MOC-31 and D2-40 must be included in routine immunocytochemistry panel for the differenciation between carcinoma and mesothelioma in neoplastic effusions.

As efusões cavitárias são de ocorrência frequente na rotina clínica de cães. Na maior parte dos casos são efusões benignas, causadas por distúrbios hidrostáticos do sistema circulatório. As neoplasias são causas comuns de efusões em cães, contudo, nem sempre as células tumorais são encontradas no exame citopatológico. A dosagem de marcadores tumorais e o exame imunocitoquímico são alternativas para tornar o diagnóstico de neoplasia em efusões mais preciso. Os objetivos deste trabalho foram dosar os seguintes marcadores tumorais bioquímicos: antígeno carcinoembrionário (CEA), antígeno associado a câncer 72-4 (CA 72-4) e fragmento de citoqueratina 21-1 (CYFRA 21-1), que ainda não tiveram seu desempenho avaliado em efusões neoplásicas e não neoplásicas caninas, bem como marcadores imunocitoquímicos que incluem dois novos anticorpos primários (MOC-31 e D2-40) para a diferenciação entre carcinoma e mesotelioma. Trinta e duas amostras de líquidos cavitários abdominais e torácicos, provenientes do atendimento clínico do Hospital de Clínicas Veterinárias da Universidade Federal do Rio Grande do Sul foram analisadas. De acordo com o exame citopatológico e ficha clínica do animal essas efusões foram classificadas em dois grupos: neoplásico e não neoplásico. A dosagem dos marcadores tumorais foi realizada pelo método imunoenzimático sanduíche (ELISA), conforme as instruções dos fabricantes. Para a avaliação imunocitoquímica foram utilizadas 14 amostras de efusões neoplásicas. A técnica foi realizada pelo método estreptavidina-biotina ligada a peroxidase ou a fosfatase alcalina, utilizando-se como cromógeno o DAB. Os marcadores tumorais CEA e CA 72-4 não tiveram resultados significativos na diferenciação entre efusões neoplásicas e não neoplásicas, enquanto que o CYFRA 21-1 obteve sensibilidade de 70%, especificidade de 94% e acurácia de 81% para o diagnóstico neoplásico. Em todas as amostras neoplásicas, imunocitoquímica e citopatologia foram compatíveis, verificando-se como válida a padronização dos novos anticorpos para a espécie canina. Este estudo demonstrou que novos marcadores tumorais, tanto bioquímicos como imunocitoquímicos, podem ser empregados no diagnóstico de neoplasias caninas. O marcador tumoral CYFRA 21-1 deve ser utilizado como auxílio diagnóstico para a espécie canina e os anticorpos MOC-31 e D2-40 devem ser incluídos em painéis imunocitoquímicos de rotina para a diferenciação entre carcinomas e mesoteliomas em efusões neoplásicas. / The cavity effusions frequently occur in the clinical routine of dogs. In most cases the effusions are benign caused by circulatory system disorders. Neoplasms are common causes of effusions in dogs, however not always the tumor cells are found in cytopathologycal analysis. The dosage of tumor markers is an alternative to make the neoplastic effusion diagnosis more accurate. The aims of this work were to determine the following biochemical tumor markers: carcinoembryonic antigen (CEA), cancer antigen 72-4 (CA 72-4) and cytokeratin fragment 21-1 (CYFRA 21-1), which have not had their performance evaluated in canine neoplastic and non-neoplastic effusions, as well as immunocytochemical markers including two new primary antibodies (MOC-31 and D2-40) for differentiation between carcinoma and mesothelioma tumors. Thrirtytwo samples of abdominal and thoracic cavity fluids, from the clinical care of the Veterinary Hospital of the Federal University of Rio Grande do Sul were analyzed. According to the cytopathology test and patient’s clinical record the effusions were classified in two groups: neoplastic or non-neoplastic. The tumor markers measurement was performed by sandwich enzyme immunoassay (ELISA) according to the manufacturer instructions. Fourteen neoplastic samples were used for the immunocytochemical tests. The tests were performed by streptavidin-biotin method linked to peroxidase or to alkaline phosphatase using the DAB chromogen. The tumor markers CEA and CA 72-4 had no significant results for differentiating between neoplastic and non neoplastic effusions, whereas the tumor marker CYFRA 21-1 obtained 70% of sensibility, 94% of specificity and 81% of accuracy for the neoplastic diagnosis. In all neoplastic samples the immunocytochemical and cytological tests were compatible, which make valid their use for standardization of those new antibodies for the canine species. This study demonstrated that new tumor markers both biochemical and immunocytochemical could be used in the canine neoplastic diagnosis. The tumor marker CYFRA 21-1 must be used for the canine species, and the antibodies MOC-31 and D2-40 must be included in routine immunocytochemistry panel for the differenciation between carcinoma and mesothelioma in neoplastic effusions.